Ubs Asset Management Americas Inc Beam Therapeutics Inc. Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 401,286 shares of BEAM stock, worth $9.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
401,286
Previous 419,569 4.36%
Holding current value
$9.65 Million
Previous $9.83 Million 0.01%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$22.57 - $33.14 $412,647 - $605,898
-18,283 Reduced 4.36%
401,286 $9.83 Million
Q2 2024

Aug 13, 2024
BUY
$21.22 - $32.66 $2.57 Million - $3.96 Million
121,223 Added 40.63%
419,569 $9.83 Million
Q1 2024

May 15, 2024
SELL
$23.46 - $45.07 $173,252 - $332,841
-7,385 Reduced 2.42%
298,346 $9.86 Million
Q4 2023

Feb 14, 2024
BUY
$17.69 - $30.76 $452,439 - $786,717
25,576 Added 9.13%
305,731 $8.32 Million
Q3 2023

Nov 13, 2023
BUY
$23.01 - $32.46 $1.02 Million - $1.43 Million
44,132 Added 18.7%
280,155 $6.74 Million
Q1 2023

May 15, 2023
SELL
$30.15 - $48.79 $376,272 - $608,899
-12,480 Reduced 5.02%
236,023 $7.23 Million
Q4 2022

Feb 14, 2023
BUY
$36.73 - $51.6 $6.97 Million - $9.79 Million
189,713 Added 322.7%
248,503 $9.72 Million
Q3 2022

Nov 14, 2022
SELL
$39.79 - $70.31 $261,738 - $462,499
-6,578 Reduced 10.06%
58,790 $2.8 Million
Q2 2022

Aug 12, 2022
BUY
$29.86 - $62.36 $614,847 - $1.28 Million
20,591 Added 45.99%
65,368 $2.53 Million
Q1 2022

May 16, 2022
BUY
$53.73 - $82.16 $231,952 - $354,684
4,317 Added 10.67%
44,777 $2.57 Million
Q4 2021

Feb 14, 2022
BUY
$68.02 - $99.06 $55,776 - $81,229
820 Added 2.07%
40,460 $3.22 Million
Q3 2021

Nov 15, 2021
BUY
$84.37 - $133.6 $159,965 - $253,305
1,896 Added 5.02%
39,640 $3.45 Million
Q2 2021

Aug 16, 2021
BUY
$64.12 - $128.71 $1.26 Million - $2.52 Million
19,593 Added 107.94%
37,744 $4.86 Million
Q1 2021

May 14, 2021
BUY
$71.28 - $120.75 $364,454 - $617,394
5,113 Added 39.22%
18,151 $1.45 Million
Q4 2020

Mar 01, 2021
BUY
$22.24 - $95.63 $289,965 - $1.25 Million
13,038 New
13,038 $1.06 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.69B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email